Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer

[1]  Karen J Gonzalez,et al.  In silico identification of potential inhibitors against human 2’-5’- oligoadenylate synthetase (OAS) proteins , 2019, Computational Biology and Chemistry.

[2]  Juan B. Gutiérrez,et al.  In silico identification of potential inhibitors against human 2’-5’-oligoadenylate synthetase (OAS) proteins , 2019, bioRxiv.

[3]  N. Beerenwinkel,et al.  Neutrophils escort circulating tumour cells to enable cell cycle progression , 2019, Nature.

[4]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[5]  M. Zheng,et al.  Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer , 2018, World Journal of Surgical Oncology.

[6]  F. Cardoso,et al.  Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015). , 2018, Breast.

[7]  J. Chen,et al.  Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins , 2018, Front. Microbiol..

[8]  J. Vilo,et al.  MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. , 2018, Epigenomics.

[9]  Young-Joon Kim,et al.  OASL1 Traps Viral RNAs in Stress Granules to Promote Antiviral Responses , 2018, Molecules and cells.

[10]  Xue Lian,et al.  Identification of a novel porcine OASL variant exhibiting antiviral activity. , 2018, Virus research.

[11]  A. Jemal,et al.  Breast cancer statistics, 2017, racial disparity in mortality by state , 2017, CA: a cancer journal for clinicians.

[12]  Jun S. Liu,et al.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.

[13]  C. Denkert,et al.  Molecular alterations in triple-negative breast cancer—the road to new treatment strategies , 2017, The Lancet.

[14]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[15]  N. Harbeck,et al.  Breast cancer , 2017, The Lancet.

[16]  A. Lánczky,et al.  miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients , 2016, Breast Cancer Research and Treatment.

[17]  P. Fagone,et al.  Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. , 2016, Antiviral research.

[18]  L. Shulman,et al.  Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality. , 2016, The oncologist.

[19]  N. Elde,et al.  Overlapping Patterns of Rapid Evolution in the Nucleic Acid Sensors cGAS and OAS1 Suggest a Common Mechanism of Pathogen Antagonism and Escape , 2015, PLoS genetics.

[20]  Young-Joon Kim,et al.  Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases , 2015, Experimental & Molecular Medicine.

[21]  N. Caplen,et al.  Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines , 2014, Clinical & Experimental Metastasis.

[22]  P. Baade,et al.  Incidence and mortality of female breast cancer in the Asia-Pacific region , 2014, Cancer biology & medicine.

[23]  S. Qiu,et al.  CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. , 2014, Carcinogenesis.

[24]  A. Martínez-Torteya,et al.  SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.

[25]  P. Desprès,et al.  The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[26]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[27]  J. Justesen,et al.  The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. , 2007, Biochimie.

[28]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[29]  G. Sen,et al.  Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. , 2003, Molecular cell.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[32]  A. Monaco,et al.  The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. , 1998, Genomics.

[33]  A. Hovanessian,et al.  Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. , 1987, The Journal of biological chemistry.

[34]  P. Feil,et al.  2',5'-oligoadenylate synthetase activity in human mammary tumors and its potential correlation with tumor growth or hormonal responsiveness. , 1986, Cancer research.